Boston Scientific MedSurg — Other segment items decreased by 80.0% to $1.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 80.0%, from $5.00M to $1.00M. Over 3 years (FY 2022 to FY 2025), MedSurg — Other segment items shows a downward trend with a -4.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate rising non-recurring operational costs or specific segment-level charges, while a decrease suggests fewer one-time expenses.
Represents miscellaneous income or expense items specifically allocated to the MedSurg business segment that do not fall...
Peers often report these as 'Other Operating Income/Expense' within segment disclosures.
bsx_segment_medsurg_other_segment_items| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.75M | $5.75M | $5.75M | $5.75M | $5.00M | $5.00M | $5.00M | $5.00M | $5.00M | $4.00M | $0.00 | $5.00M | $6.00M | $8.00M | $5.00M | $1.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -13.0% | +0.0% | +0.0% | +0.0% | +0.0% | -20.0% | -100.0% | — | +20.0% | +33.3% | -37.5% | -80.0% |
| YoY Change | — | — | — | — | -13.0% | -13.0% | -13.0% | -13.0% | +0.0% | -20.0% | -100.0% | +0.0% | +20.0% | +100.0% | — | -80.0% |